C86.00 — Extranodal NK/T-cell lymphoma, nasal type not having achieved remission
C86.00 is a billable, specific ICD-10-CM code for extranodal nk/t-cell lymphoma, nasal type not having achieved remission. It is valid for submission on a claim.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Extranodal NK/T-cell lymphoma, nasal type NOS
- Extranodal NK/T-cell lymphoma, nasal type with failed remission
Other codes that can never be billed with C86.00
These codes carry an Excludes1 note pointing at C86.00. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading C86.00 alone.
- C84.ZOther mature T/NK-cell lymphomas
Risk adjustment
C86.00 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 20 Lung and Other Severe Cancers1.136 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C86.00 is named in 40 Medicare coverage policies — 40 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
- A52479Oral Anticancer Drugs - Policy Article
Related codes at this level
Codes that share C86.0. If C86.00 is not quite right, the correct code is usually one of these.
Questions about C86.00
- Is C86.00 a billable ICD-10-CM code?
- Yes. C86.00 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C86.00 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).